Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Human CD3 (T3, CD3ε) In Vivo PLATINUM; Clone UCHT-1; Isotype: Mouse IgG1
SDP

Supplier:  Leinco Technologies Inc C6645.0 MG

Encompass_Preferred

Specificity: Clone UCHT-1 binds to the human CD3ε-chain. Antigen Distribution: CD3 is expressed on human peripheral blood lymphocytes, splenic lymphocytes, the majority of T-CLL and T-ALL cells. Background: CD3ε is a T-cell surface glycoprotein and is a 20-kDa subunit of the TCR complex used for enumerating immunocompetent T-lymphocytes in peripheral blood. CD3 is involved in signal transduction during antigen recognition. Applications: (FC, IP, WB) Clone UCHT-1 is also useful in histology for localization of T-lymphocytes in tissue and may be used to enrich T-cells by cell sorting. This T-cell marker has also been used to determine T-versus B-cell lymphomas and leukemias. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6189


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.